170 related articles for article (PubMed ID: 10498627)
21. Tyrosine 425 within the activated erythropoietin receptor binds Syp, reduces the erythropoietin required for Syp tyrosine phosphorylation, and promotes mitogenesis.
Tauchi T; Damen JE; Toyama K; Feng GS; Broxmeyer HE; Krystal G
Blood; 1996 Jun; 87(11):4495-501. PubMed ID: 8639815
[TBL] [Abstract][Full Text] [Related]
22. Induction of tyrosine phosphorylation of Vav and expression of Pim-1 correlates with Jak2-mediated growth signaling from the erythropoietin receptor.
Miura O; Miura Y; Nakamura N; Quelle FW; Witthuhn BA; Ihle JN; Aoki N
Blood; 1994 Dec; 84(12):4135-41. PubMed ID: 7527668
[TBL] [Abstract][Full Text] [Related]
23. A novel mechanism of cooperation between c-Kit and erythropoietin receptor. Stem cell factor induces the expression of Stat5 and erythropoietin receptor, resulting in efficient proliferation and survival by erythropoietin.
Kapur R; Zhang L
J Biol Chem; 2001 Jan; 276(2):1099-106. PubMed ID: 11042182
[TBL] [Abstract][Full Text] [Related]
24. Low doses of EPO activate MAP kinases but not JAK2-STAT5 in rat vascular smooth muscle cells.
Ammarguellat F; Llovera M; Kelly PA; Goffin V
Biochem Biophys Res Commun; 2001 Jun; 284(4):1031-8. PubMed ID: 11409898
[TBL] [Abstract][Full Text] [Related]
25. The distal cytoplasmic domain of the erythropoietin receptor induces granulocytic differentiation in 32D cells.
Harris KW; Hu XJ; Schultz S; Arcasoy MO; Forget BG; Clare N
Blood; 1998 Aug; 92(4):1219-24. PubMed ID: 9694710
[TBL] [Abstract][Full Text] [Related]
26. Epo-induced hemoglobinization of SKT6 cells is mediated by minimal cytoplasmic domains of the Epo or prolactin receptors without modulation of GATA-1 or EKLF.
Reese TT; Gregory RC; Sharlow ER; Pacifici RE; Crouse JA; Todokoro K; Wojchowski DM
Growth Factors; 1997; 14(2-3):161-76. PubMed ID: 9255607
[TBL] [Abstract][Full Text] [Related]
27. STAT5 activation correlates with erythropoietin receptor-mediated erythroid differentiation of an erythroleukemia cell line.
Iwatsuki K; Endo T; Misawa H; Yokouchi M; Matsumoto A; Ohtsubo M; Mori KJ; Yoshimura A
J Biol Chem; 1997 Mar; 272(13):8149-52. PubMed ID: 9079629
[TBL] [Abstract][Full Text] [Related]
28. A possible involvement of Stat5 in erythropoietin-induced hemoglobin synthesis.
Wakao H; Chida D; Damen JE; Krystal G; Miyajima A
Biochem Biophys Res Commun; 1997 May; 234(1):198-205. PubMed ID: 9168989
[TBL] [Abstract][Full Text] [Related]
29. Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway.
Okutani Y; Kitanaka A; Tanaka T; Kamano H; Ohnishi H; Kubota Y; Ishida T; Takahara J
Oncogene; 2001 Oct; 20(45):6643-50. PubMed ID: 11641791
[TBL] [Abstract][Full Text] [Related]
30. EPO receptor gain-of-function causes hereditary polycythemia, alters CD34 cell differentiation and increases circulating endothelial precursors.
Perrotta S; Cucciolla V; Ferraro M; Ronzoni L; Tramontano A; Rossi F; Scudieri AC; Borriello A; Roberti D; Nobili B; Cappellini MD; Oliva A; Amendola G; Migliaccio AR; Mancuso P; Martin-Padura I; Bertolini F; Yoon D; Prchal JT; Della Ragione F
PLoS One; 2010 Aug; 5(8):e12015. PubMed ID: 20700488
[TBL] [Abstract][Full Text] [Related]
31. Delayed hemoglobin switching and perinatal neocytolysis in mice with gain-of-function erythropoietin receptor.
Divoky V; Song J; Horvathova M; Kralova B; Votavova H; Prchal JT; Yoon D
J Mol Med (Berl); 2016 May; 94(5):597-608. PubMed ID: 26706855
[TBL] [Abstract][Full Text] [Related]
32. Genetic variants of erythropoietin (EPO) and EPO receptor genes in familial erythrocytosis.
Vočanec D; Prijatelj T; Debeljak N; Kunej T
Int J Lab Hematol; 2019 Apr; 41(2):162-167. PubMed ID: 30507031
[TBL] [Abstract][Full Text] [Related]
33. Hematopoietic cell survival signals are elicited through non-tyrosine-containing sequences in the membrane-proximal region of the erythropoietin receptor (EPOR) by a Stat5-dependent pathway.
Yoon D; Watowich SS
Exp Hematol; 2003 Dec; 31(12):1310-6. PubMed ID: 14662339
[TBL] [Abstract][Full Text] [Related]
34. Erythropoietin induces activation of Stat5 through association with specific tyrosines on the receptor that are not required for a mitogenic response.
Quelle FW; Wang D; Nosaka T; Thierfelder WE; Stravopodis D; Weinstein Y; Ihle JN
Mol Cell Biol; 1996 Apr; 16(4):1622-31. PubMed ID: 8657137
[TBL] [Abstract][Full Text] [Related]
35. Two new EPO receptor mutations: truncated EPO receptors are most frequently associated with primary familial and congenital polycythemias.
Kralovics R; Indrak K; Stopka T; Berman BW; Prchal JF; Prchal JT
Blood; 1997 Sep; 90(5):2057-61. PubMed ID: 9292543
[TBL] [Abstract][Full Text] [Related]
36. Erythropoietin-mediated activation of JAK-STAT signaling contributes to cellular invasion in head and neck squamous cell carcinoma.
Lai SY; Childs EE; Xi S; Coppelli FM; Gooding WE; Wells A; Ferris RL; Grandis JR
Oncogene; 2005 Jun; 24(27):4442-9. PubMed ID: 15856028
[TBL] [Abstract][Full Text] [Related]
37. The frequency of JAK2 exon 12 mutations in idiopathic erythrocytosis patients with low serum erythropoietin levels.
Percy MJ; Scott LM; Erber WN; Harrison CN; Reilly JT; Jones FG; Green AR; McMullin MF
Haematologica; 2007 Dec; 92(12):1607-14. PubMed ID: 18055983
[TBL] [Abstract][Full Text] [Related]
38. CIS3/SOCS-3 suppresses erythropoietin (EPO) signaling by binding the EPO receptor and JAK2.
Sasaki A; Yasukawa H; Shouda T; Kitamura T; Dikic I; Yoshimura A
J Biol Chem; 2000 Sep; 275(38):29338-47. PubMed ID: 10882725
[TBL] [Abstract][Full Text] [Related]
39. The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anemia in chronic hemodialysis patients.
Akagi S; Ichikawa H; Okada T; Sarai A; Sugimoto T; Morimoto H; Kihara T; Yano A; Nakao K; Nagake Y; Wada J; Makino H
J Am Soc Nephrol; 2004 Dec; 15(12):3215-24. PubMed ID: 15579525
[TBL] [Abstract][Full Text] [Related]
40. Erythropoietin stimulates proliferation and interferes with differentiation of myoblasts.
Ogilvie M; Yu X; Nicolas-Metral V; Pulido SM; Liu C; Ruegg UT; Noguchi CT
J Biol Chem; 2000 Dec; 275(50):39754-61. PubMed ID: 10995753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
